Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 14 - Number 4
Editorial
Editorial (Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases)
, 14(4): 301Xiao-Ping Wang and Hong-Zhuan Chen
DOI: 10.2174/1570159X1404160408124344
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
, 14(4): 302 - 306Li-Li Zhang, S. Duff Canning and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151201190040
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
, 14(4): 307 - 313Feng Wang, Ting-Yi Feng, Shilin Yang, Maurice Preter, Jiang-Ning Zhou and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151208114232
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
, 14(4): 314 - 321Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang
DOI: 10.2174/1570159X14666160120152423
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Current Drug Managements of Wilson’s Disease: From West to East
, 14(4): 322 - 325Wen-Jie Li, Chen Chen, Zhi-Fei You, Ren-Min Yang and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151130222427
Current Drug Managements of Wilson’s Disease: From West to East
Current Treatment Options for Alzheimer’s Disease and Parkinson’s Disease Dementia
, 14(4): 326 - 338Jennifer Y.Y. Szeto and Simon J.G. Lewis
DOI: 10.2174/1570159X14666151208112754
Current Treatment Options for Alzheimer’s Disease and Parkinson’s Disease Dementia
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
, 14(4): 339 - 355Jie Dong, Yanhua Cui, Song Li and Weidong Le
DOI: 10.2174/1570159X14666151120123025
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
, 14(4): 356 - 363Jinglin Zhang and Louis Chew-Seng Tan
DOI: 10.2174/1570159X14666151208114634
Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
, 14(4): 364 - 375Yu Wang, Hao Wang and Hong-zhuan Chen
DOI: 10.2174/1570159X14666160119094820
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
, 14(4): 376 - 391Mine Silindir Gunay, A. Yekta Ozer and Sylvie Chalon
DOI: 10.2174/1570159X14666151230124904
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
, 14(4): 392 - 402Cássia Righy, Marcelo T. Bozza, Marcus F. Oliveira and Fernando A. Bozza
DOI: 10.2174/1570159X14666151230110058
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net